BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2857790)

  • 1. Pharmacological analysis of alpha-2 adrenergic mechanisms in nociception and ataxia.
    Luttinger D; Ferrari R; Perrone MH; Haubrich DR
    J Pharmacol Exp Ther; 1985 Mar; 232(3):883-9. PubMed ID: 2857790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "Spare" alpha 1-adrenergic receptors and the potency of agonists in rat vas deferens.
    Minneman KP; Abel PW
    Mol Pharmacol; 1984 Jan; 25(1):56-63. PubMed ID: 6143249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsynaptic alpha 2-adrenoceptors predominate over alpha 1-adrenoceptors in canine tracheal smooth muscle and mediate neuronal and hormonal alpha-adrenergic contraction.
    Barnes PJ; Skoogh BE; Nadel JA; Roberts JM
    Mol Pharmacol; 1983 May; 23(3):570-5. PubMed ID: 6135147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparent pA2 estimates for an antinociceptive receptor.
    Parale MP; Kulkarni SK
    Arch Int Pharmacodyn Ther; 1985 May; 275(1):59-67. PubMed ID: 2862851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced alpha2A-autoreceptor reserve for clonidine induced by reserpine and cholinomimetic agents in the rat vas deferens.
    Pineda J; Ugedo L; García-Sevilla JA
    Br J Pharmacol; 1997 Nov; 122(5):833-40. PubMed ID: 9384498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of central alpha-2 adrenergic compounds on canine narcolepsy, a disorder of rapid eye movement sleep.
    Nishino S; Haak L; Shepherd H; Guilleminault C; Sakai T; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1990 Jun; 253(3):1145-52. PubMed ID: 1972749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of alpha 1-adrenergic receptors and contraction of rat vas deferens.
    Minneman KP; Fox AW; Abel PW
    Mol Pharmacol; 1983 Mar; 23(2):359-68. PubMed ID: 6300645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reserpine-induced postjunctional supersensitivity in rat vas deferens and caudal artery without changes in alpha adrenergic receptors.
    Nasseri A; Barakeh JF; Abel PW; Minneman KP
    J Pharmacol Exp Ther; 1985 Aug; 234(2):350-7. PubMed ID: 2991496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of agonistic and antagonistic actions of guanabenz and guanfacin on alpha 1 and alpha 2-adrenoceptors in isolated smooth muscles.
    Takeuchi K; Kogure M; Hashimoto T
    Jpn J Pharmacol; 1987 Mar; 43(3):267-75. PubMed ID: 2884339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of alpha 2 adrenoreceptors on arterial smooth muscle and brain homogenates from spontaneously hypertensive and Wistar-Kyoto normotensive rats.
    Weiss RJ; Webb RC; Smith CB
    J Hypertens; 1984 Jun; 2(3):249-55. PubMed ID: 6099386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of alpha2-adrenoceptors in Fischer 344 and Lewis rats. Evidence for clonidine-induced place aversion.
    Herradón G; Morales L; Gramage E; Alguacil LF
    Life Sci; 2008 Jun; 82(23-24):1186-90. PubMed ID: 18479715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ablation of the myenteric plexus impairs alpha but not beta adrenergic receptor-mediated mechanical responses of rat jejunal longitudinal muscle.
    Fox DA; Bass P
    J Pharmacol Exp Ther; 1986 Oct; 239(1):9-14. PubMed ID: 2876094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
    Roach AG; Doxey JC; Strachan DA; Cavero I
    J Pharmacol Exp Ther; 1983 Nov; 227(2):421-8. PubMed ID: 6138427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pharmacological classification of adrenergic alpha 1 and alpha 2 receptors and their mechanisms of action.
    Wikberg JE
    Acta Physiol Scand Suppl; 1979; 468():1-99. PubMed ID: 42274
    [No Abstract]   [Full Text] [Related]  

  • 15. [The alpha-adrenergic sensitivity of smooth muscle following sympathectomy].
    Telina EN; Khamitov KhS; Akhmedzianov RKh
    Fiziol Zh SSSR Im I M Sechenova; 1988 Sep; 74(9):1287-93. PubMed ID: 2905677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effect of agmatine in the bisected rat vas deferens.
    Santos WC; Smaili SS; Jurkiewicz A; Piçarro I; Garcez-do-Carmo L
    J Pharm Pharmacol; 2003 Mar; 55(3):373-80. PubMed ID: 12724044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenergic regulation of blood glucose levels: possible involvement of postsynaptic alpha-2 type adrenergic receptors regulating insulin release.
    Nakadate T; Nakaki T; Muraki T; Kato R
    J Pharmacol Exp Ther; 1980 Oct; 215(1):226-30. PubMed ID: 6109015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive and sedative effects of alpha-adrenoceptor agonists: relationship to alpha 1- and alpha 2-adrenoceptor potency.
    Clough DP; Hatton R
    Br J Pharmacol; 1981 Jul; 73(3):595-604. PubMed ID: 6113864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of subchronic exposure of rats to lead or zinc on alpha-adrenoceptor-mediated contractile responses in isolated vas deferens.
    Mutafova-Yambolieva V; Staneva-Stoytcheva D; Lasova L; Radomirov R
    Acta Physiol Pharmacol Bulg; 1993; 19(4):111-9. PubMed ID: 8203281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-synaptic alpha-adrenoceptor regulation of the twitch response of the mouse vas deferens [proceedings].
    Marshall I; Nasmyth PA; Nicholl CG; Shepperson NB
    Br J Pharmacol; 1977 Mar; 59(3):510P. PubMed ID: 191133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.